試す 金 - 無料
FAST & FURIOUS
THE WEEK India
|December 15, 2024
The rapid growth of quick commerce is reshaping India's retail shopping scene. Not everyone is happy about it, though
It was when he was stuck at home during the Covid pandemic that Mumbai boy Aadit Palicha noticed the struggles of his elderly neighbours in getting their daily groceries. It led to a billion-dollar idea, which today has some of the biggest companies in the world, from Amazon to Reliance, playing catch-up to.
What Aadit and Kaivalya Vohra, both 18 then, kickstarted by delivering medicines and groceries to the needy neighbours on bicycle has blossomed into Zepto, a startup worth a mind-boggling ₹30,000 crore valuation, in just around three years. In the process, they have become India's youngest billionaires, according to the Hurun Rich List released a month ago. "Quick commerce is no longer just about stocking up on necessities. It caters to diverse needs, allowing users to skip the planning phase and instantly access a wide assortment of items in one place," said Aadit, who celebrated his 22nd birthday along with the billionaire status.
Quick commerce, as the name suggests, is an online market service which assures delivery at lightning speed. While a regular order, say on Flipkart or Amazon, may take a few days depending on the item, quick commerce promises delivery in minutes.
A lot of data crunching and predictive algorithms make it work, whereby players like Zepto and BlinkIt set up dark stores in high catchment areas and stock up on items that are likely to be ordered. "The market is shifting towards the quick commerce version," said Srinivasa Reddy, assistant professor, marketing management, T.A. Pai Management Institute, Manipal. "And, we are also seeing a maturity because customers are willing to trust this even for an ice cream!"
このストーリーは、THE WEEK India の December 15, 2024 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
THE WEEK India からのその他のストーリー
THE WEEK India
Fire, smoke and soaring worries
The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility
7 mins
January 25, 2026
THE WEEK India
The dinosaur and the dictator
Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.
2 mins
January 25, 2026
THE WEEK India
We are developing master plans for tourism destinations
Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.
2 mins
January 25, 2026
THE WEEK India
A TIGHTROPE WALK
As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them
4 mins
January 25, 2026
THE WEEK India
ON THIN ICE
With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient
5 mins
January 25, 2026
THE WEEK India
Elgin, Ephesus and Erdogan
Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.
2 mins
January 25, 2026
THE WEEK India
Art at the heart
The sixth edition of the Kochi-Muziris Biennale reclaims its legacy
6 mins
January 25, 2026
THE WEEK India
BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options
Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.
2 mins
January 25, 2026
THE WEEK India
ERA OF THE NEW NORMAL
The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military
5 mins
January 25, 2026
THE WEEK India
Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India
For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.
1 mins
January 25, 2026
Listen
Translate
Change font size

